Benzyl 2,4-dichloro-5,6-dihydropyrido[3,4-d]pyriMidine-7(8H)-carboxylate manufacturers
|
| | Benzyl 2,4-dichloro-5,6-dihydropyrido[3,4-d]pyriMidine-7(8H)-carboxylate Basic information | | Uses Application |
| Product Name: | Benzyl 2,4-dichloro-5,6-dihydropyrido[3,4-d]pyriMidine-7(8H)-carboxylate | | Synonyms: | Benzyl 2,4-dichloro-5,6-dihydropyrido[3,4-d]pyriMidine-7(8H)-carboxylate;Benzyl 2,4-dichloro-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H);benzyl 2,4-dichloro-6,8-dihydro-5H-pyrido[3,4-d]pyrimidine-7-carboxylate;7-Cbz-2,4-dichloro-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine;Pyrido[3,4-d]pyrimidine-7(6H)-carboxylic acid, 2,4-dichloro-5,8-dihydro-, phenylmethyl ester;Phenylmethyl 2,4-dichloro-5,8-dihydropyrido[3,4-d]pyrimidine-7(6H)-carboxylate;benzyl 2,4-dichloro-5,8-dihydropyrido[3,4-d]pyrimidine-7(6H)-carboxylate | | CAS: | 1370411-44-1 | | MF: | C15H13Cl2N3O2 | | MW: | 338.19 | | EINECS: | | | Product Categories: | Heterocycle-Pyrimidine series | | Mol File: | 1370411-44-1.mol | ![Benzyl 2,4-dichloro-5,6-dihydropyrido[3,4-d]pyriMidine-7(8H)-carboxylate Structure](CAS/GIF/1370411-44-1.gif) |
| | Benzyl 2,4-dichloro-5,6-dihydropyrido[3,4-d]pyriMidine-7(8H)-carboxylate Chemical Properties |
| Boiling point | 508.8±50.0 °C(Predicted) | | density | 1.433±0.06 g/cm3(Predicted) | | storage temp. | under inert gas (nitrogen or Argon) at 2-8°C | | pka | -2.00±0.20(Predicted) | | Appearance | White to off-white Solid | | InChI | InChI=1S/C15H13Cl2N3O2/c16-13-11-6-7-20(8-12(11)18-14(17)19-13)15(21)22-9-10-4-2-1-3-5-10/h1-5H,6-9H2 | | InChIKey | XLMNHZAOTDBGMV-UHFFFAOYSA-N | | SMILES | C1(Cl)=NC(Cl)=C2CCN(C(OCC3=CC=CC=C3)=O)CC2=N1 |
| | Benzyl 2,4-dichloro-5,6-dihydropyrido[3,4-d]pyriMidine-7(8H)-carboxylate Usage And Synthesis |
| Uses | N-CBZ-2,4-dichloro-5,6,7,8-tetrahydropyridine[3,4-D]pyrimidine is a pharmaceutical intermediate used to prepare the compound 1-(2-(methoxymethyl)-4-(2-(((S)-1-methylpyrrolidin-2-yl)methoxy)-7-(naphth-1-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl)piperazin-1-yl)prop-2-en-1-one, which is a KRASG12C inhibitor. | | Application | N-CBZ-2,4-dichloro-5,6,7,8-tetrahydropyridine[3,4-D]pyrimidine is a pyrimidine organic compound that can be used as a pharmaceutical intermediate. |
| | Benzyl 2,4-dichloro-5,6-dihydropyrido[3,4-d]pyriMidine-7(8H)-carboxylate Preparation Products And Raw materials |
|